Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease

Annals of the Rheumatic Diseases

Volumn 56, Issue 11, 1997, Pages 656-660

  Van Roon, Joel A G ^a   Verhoef, Catherina M ^a   Van Roy, Johanna L A M ^a   Gmelig Meyling, Frits H J ^a   Huber Bruning, Olga ^a   Lafeber, Floris P J G ^a   Bijlsma, Johannes W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0031457824     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.11.656     Document Type: Article

References (33)

1. Mosmann T R, Cherwinski H, Bond M, Giedlin M A, Coffman R L. Two types of murine helper T-cell clone. 1 Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
2. Del Prete G F, De Carli M, Mastromauro C, Macchia D, Biagiotti R, Ricci M, et al. Purified protein derivative of Mycobacterium tuberculosis and exretory-secretory antigens of Toxocara canis expand in vitro human T-cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346-50.
3. Romagnani S. Lymphokine production by human T-cells in disease states. Annu Rev Immunol 1994;12:227-57.
4. Nouri A M E, Panayi G S, Goodman S M. Cytokines and chronic inflammation of rheumatic disease. I. The presence of IL-1 in synovial fluids. Clin Exp Immunol 1984;55:295-302.
5. Saxne T, Palladino M A, Heinegard D, Talal N, Wollheim F A. Detection of tumor necrosis factor a but not tumor necrosis β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-6.
6. Ulfgren A-K, Lindblad S, Klareskog L, Andersson J, Andersson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:654-61.
7. Westacott C I, Whicher J T, Barnes I C, Thompson D, Swan A J, Dieppe P A. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 1990; 49:676-81.
8. Kahle P, Saal J G, Schaudt K, Zacher J, Fritz P, Pawelec G. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 1992;51:731-4.
9. Sipe J D, Martel-Pelletier J, Otterness I G, Pelletier J P. Cytokine reduction in the treatment of joint conditions. Mediators of Inflammation 1994;3:243-56.
10. Miltenburg A M M, Van Laar J M, De Kuiper R, Daha M R, Breedveld F C. T-cells from human rheumatoid synovial membrane functionally represent the ThI subset. Scand J Immunol 1992;35:603-10.
11. Quayle A J, Chomarat P, Miossec P, Kjeldsenkragh J, Førre Ø, Natvig J B. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 1993;38:75-82.
12. Dolhain R J E M, Van der Heiden A N, Ter Haar N T, Breedveld F C, Miltenburg A M M. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1961-9.
13. Simon AK, Seipelt E, Sieper J. Divergent T cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci 1994;91:8562-6.
14. Bucht A, Larsson P, Weisbrot L, Thorne C, Pisa P, Smedegard G, et al. Expression of interferon-gamma (IFN-γ), IL-10, IL-12 and transforming growth factor-beta (TGF-β) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996;103:357-67.
15. Franchimont P, Reuter A, Vrindts-Gevaert Y, Bastings M, Malaise M, Sondag C, et al. Production of tumor necrosis factor-α, interferon-γ and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arhthritis. Scand J Rheumatol 1988;17:203-12.
16. Ruschen S, Stellberg W, Warnatz H. Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls. Clin Exp Immunol 1992;89:32 7.
17. Pene J, Rivier A, Lagier B, Becker W M, Michel W M, Bousquet J. Differences in IL-4 release by PBMNC are related with heterogeneity of atopy. Immunology 1994;81: 58-64.
18. King C L, Low C C, Nutman T B: IgE production in human helminth infection. Reciprocal interrelationship between IL-4 and IFN-γ. J Immunol 1993;150:1873-80.
19. Van Lier R A W, Brouwer M, Aarden L A. Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies. Eur J Immunol 1988;18:167-72.
20. Van der Pouw-Kraan T, Van Kooten C, Rensink I, Aarden L. Interleukin-4 production by human T cells; differential regulation of IL-4 vs. IL-4 production. Eur J Immunol 1992;22:1237-41.
21. June C H, Bluestone J A, Nadler L M, Thompson C B. The B7 and CD28 receptor families. Immunol Today 1994;15: 321-31.
22. Arnett F C, Edworthy S M, Bloch D A, McShane D J, Fries J F, Cooper N S, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315 24.
23. Steinbrocker O, Traeger C H, Batterman R C. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
24. Al-Janadi M, Al-Dalaan A, Al-Balla S, Raziuddin S. CD4+ T cell inducible immunoregulatory cytokine response in rheumatoid arthritis. J Rheumatol 1996;23:809 14.
25. Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, et al. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997;385:81-3.
26. Schulze-Koops H, Lipsky P E, Kavanaugh F, Davies L S. Elevated TH1-like cytokine mRNA in the peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with a monoclonal antibody to ICAM-1. J Immunol 1995;155:5029 37.
27. Rivas D, Mozo L, Zamorano J, Gayo A, Torre-Alonso JC, Rodriguez A, et al. Upregulated expression of IL-4 receptors and increased levels of IL-4 in rheumatoid arthritis patients. J Autoimmun 1995;8:587 600.
28. Miossec P, Naviliat M, Dupuy D'Angeac A, Sany J, Banchereau J. Low levels of IL-4 and high levels of transforming growth factor β in rheumatoid synovitis. Arthritis Rheum 1990;33:1180-7.
29. Lotz M, Kekow J, Carson D A. Transforming growth factor-β and cellular immune responses in synovial fluids. J Immunol 1990;144:4189-94.
30. Katsikis P D, Chu C Q, Brennan F M, Mami R N, Feldmann M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994;179:1517 27.
31. Cush J J, Splawski J B, Thomas R, McFarlin J E, Schulze-Koops H, Davies L S, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96 104.
32. Van Roon J A G, Van Roy J L A M, Duits A, Lafeber F P J G, Bijlsma J W J. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T-helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 1995;54:836-40.
33. Van Roon JAG, Van Roy JLAM, Gmelig-Meyling FPJ, Lafeber FPJG, Bijlsma JWJ. Prevention and reversal of cartilage degradation by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.